Plenum of the All-Union Scientific Society of Obstetricians and Gynaecologists

1986 ◽  
Vol 67 (1) ◽  
pp. 71-72
Author(s):  
Z. Sh. Gilyazutdinova
Keyword(s):  
Risk Factors ◽  
Kidney Disease ◽  
Pregnant Women ◽  
Plenary Session ◽  
Morbidity And Mortality ◽  
Chronic Tonsillitis ◽  
Scientific Society ◽  
Perinatal Morbidity ◽  
Topical Issue

The plenary session was devoted to the topical issue of reducing maternal and perinatal morbidity and mortality in late toxicosis of pregnant women. Attention was drawn to the risk factors in the development of this pathology and, first of all, to extragenital diseases of the mother: kidney disease (G. M. Savelyeva, V. N. Serov), chronic tonsillitis, high infectious index in childhood, tonsillectomy during menarche.

Modern concepts of etiology, pathogenesis and risk factors for preeclampsia

2021 ◽  
Vol 70 (5) ◽  
pp. 105-116
Author(s):  
Maria Yu. Abramova ◽  
Mikhail I. Churnosov
Keyword(s):  
Risk Factors ◽  
Social Issue ◽  
Chronic Diseases ◽  
Molecular Mechanisms ◽  
Current Understanding ◽  
Morbidity And Mortality ◽  
Perinatal Morbidity ◽  
Distant Future

Preeclampsia is a serious complication of pregnancy and complicates its course in 2-8% of all cases. According to the literature, the disease is associated with an increase in maternal and perinatal morbidity and mortality, and is a predictor of the development of chronic diseases in the distant future, which is an important medical and social issue. Of particular interest is the study of the molecular mechanisms of etiopathogenesis and risk factors for preeclampsia, which, unfortunately, are currently poorly studied and understood, thus dictating the need for further study of this complication of pregnancy. This article discusses the current understanding of the etiology, pathogenesis and risk factors for preeclampsia.

scholarly journals Influence of the Human Development Index on the Maternal–Perinatal Morbidity and Mortality of Pregnant Women with SARS-CoV-2 Infection: Importance for Personalized Medical Care

2021 ◽  
Vol 10 (16) ◽  
pp. 3631
Author(s):  
Yolanda Cuñarro-López ◽  
Santiago García-Tizón Larroca ◽  
Pilar Pintado-Recarte ◽  
Concepción Hernández-Martín ◽  
Pilar Prats-Rodríguez ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Human Development ◽  
Human Development Index ◽  
Maternal Morbidity ◽  
Tertiary Care ◽  
Country Of Origin ◽  
Morbidity And Mortality ◽  
Inverse Association ◽  
Perinatal Morbidity ◽  
Development Index

Coronavirus disease-19 (COVID-19) is perhaps the most worrisome pandemic in the 21st century, having entailed devastating consequences for the whole society during the last year. Different studies have displayed an existing association between pregnancy and COVID-19 severity due to the various physiological changes that occur during gestation. Recent data identified maternal country of origin as an important determinant of COVID-19 presentation in pregnant women. However, the explanation of this fact remains to be fully elucidated. Therefore, the purpose of this work is to analyze the possible relationship between Human Development Index (HDI) of maternal country of origin with the morbimortality of pregnant women and their newborns. Here, we conducted a multicentric, ambispective, observational case-control study (1:1 ratio) and compare with the HDI of each country (group 1—very high HDI, group 2—high HDI, group 3—medium HDI, and group 4—low HDI). In total, 1347 pregnant women with confirmed SARV-CoV-2 infection (cases) were enrolled, and each was paired with one control to give a total number of 2694 participants from 81 tertiary care centers. Among the women with SARS-CoV-2 infection, more cases were produced of perinatal mortality, overall maternal morbidity, COVID-19 maternal morbidity, C-sections, hypertensive maternal morbidity, and perinatal morbidity. Our results described an inverse association between HDI and maternofetal morbidity and mortality. Moreover, the countries with an HDI lower than 1 showed higher rates of patients with maternal COVID-19-related morbidity (6.0% vs. 2.4%, p < 0.001), a need for oxygen therapy (4.7% vs. 1.8%, p < 0.001), and maternal ICU admission (2.6% vs. 1.0%, p = 0.007). Compared to other risk factors such as overweight, obesity, preexisting and obstetric comorbidities, HDI emerged as an independent risk factor explaining much of the increased maternal–perinatal morbidity and mortality detected in our group of cases. Further research is needed to establish to confirm the real impact of this factor and its components on pregnancy outcomes.

scholarly journals The clinical experience of Gynipral application in pregnant and during labor

1999 ◽  
Vol 48 (2) ◽  
pp. 22-26
Author(s):  
M. A. Repina ◽  
N. V. Kulagina ◽  
Ya. A. Kornilova
Keyword(s):  
Pregnant Women ◽  
Clinical Experience ◽  
Morbidity And Mortality ◽  
Mortality Reduction ◽  
Perinatal Morbidity ◽  
Urgent Problem ◽  
Premature Labor ◽  
Practical Application

In modern obstetrics there is an urgent problem of treatment of threat of premature labor being one of the basic reasons for perinatal losses. In the article the prospects of Gynipral application in pregnant women, and also the results of practical application of a drug in clinic are considered. It is proved, that the application of beta-adrenomimetic Gynipral allows effectively and without development of complications on the part of the mother to carry out the treatment of premature labor threat, hypoxia a fetus, discoordination in labor, that provides the perinatal morbidity and mortality reduction.

scholarly journals Maternal and perinatal mortality, morbidity and risk factor evaluation in ante partum hemorrhage associated with Placenta Praevia

2013 ◽  
Vol 1 (2) ◽  
pp. 65-70
Author(s):  
Farhana Kalam ◽  
Mohammad Omar Faruq ◽  
Saleha Begum Chowdhury
Keyword(s):  
Risk Factors ◽  
Prenatal Care ◽  
Hemorrhagic Shock ◽  
Post Partum ◽  
Tertiary Care ◽  
Placenta Praevia ◽  
Morbidity And Mortality ◽  
Teaching Hospitals ◽  
Perinatal Morbidity ◽  
Cross Sectional

Objective: To determine the maternal & perinatal morbidity and mortality associated with Placenta Praevia in Bangladesh. To assess the risk factors of antepartum hemorrhage associated with Placenta Praevia. Design: A cross sectional observational hospital based descriptive study. Setting: Obstetric inpatient units of two tertiary care teaching hospitals of Dhaka. Participants: One hundred pregnant mothers with diagnosis or Placenta Praevia proven by pelvic ultra sonography presenting with ante partum hemorrhage . Outcome: Incidence of maternal and fetal morbidity and mortality and risk factors of ante partum hemorrhage in Placenta Praevia. Results: 38% study mothers had no ante natal care. There was no maternal death. 96% of mothers were delivered by Caesarean Section. Incidence of primary post partum hemorrhage was 38%. There were 21% still birth and 16% neonatal death. 47% mothers had no complication after delivery. 22% mothers presented with hemorrhagic shock. 59% delivered babies had birth weight below 2.5 kg and 55% delivered babies had no complication. 57% mothers belonged to low socio economic group. Conclusion: The study reflects status of mothers presenting with Placenta Praevia with perinatal morbidity and mortality in a small urban population of Bangladesh treated at two tertiary care hospitals of Dhaka. It is recommended that mothers with Placenta Praevia need to have access to prenatal care and at the same time need to be educated about the benefit of prenatal care. Emergency management of ante partum hemorrhage with hemorrhagic shock should be widely available to improve the outcome of Placenta Praevia in our population. DOI: http://dx.doi.org/10.3329/bccj.v1i2.17197 Bangladesh Crit Care J September 2013; 1 (2): 65-70

Sickle cell disease and pregnancy outcomes: population-based study on 8.8 million births

2014 ◽  
Vol 42 (4) ◽  
Author(s):  
Nada Alayed ◽  
Abbas Kezouh ◽  
Lisa Oddy ◽  
Haim A. Abenhaim
Keyword(s):  
Risk Factors ◽  
Sickle Cell Disease ◽  
Pregnant Women ◽  
Sickle Cell ◽  
Perinatal Outcomes ◽  
Population Based ◽  
Morbidity And Mortality ◽  
Cell Disease ◽  
Sickle Cell Crisis ◽  
Hemoglobin Variants

AbstractTo estimate the prevalence of sickle cell disease (SCD) in pregnancy, and to measure risk factors, morbidity, and mortality among women with SCD with and without crisis at the time of birth.We conducted a population-based, retrospective cohort study on all births in the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (HCUP-NIS) from 1999 to 2008. Births to SCD with and without crisis were identified using ICD-9 codes. Adjusted effects of risk factors and outcomes were estimated using logistic regression analyses. Effect of hemoglobin variants among women with SCD was analyzed as a predictor of crisis.There were 4262 births to women with SCD for an overall prevalence of 4.83 per 10,000 deliveries. 28.5% of women with SCD developed crisis at the time of delivery. The maternal mortality rate was 1.6 per 1000 deliveries in women with SCD, compared to 0.1 per 1000 in women without SCD. Pregnant women with SCD had a higher risk of developing preeclampsia, eclampsia, venous thromboembolism, cardiomyopathy, intrauterine fetal demise, and intrauterine growth restriction. Cesarean delivery rates were higher in women with SCD. Among the 1898 SCD women with identified hemoglobin variants, homozygous SS was the greatest risk factor for sickle cell crisis, accounting for 89.8% of all women who developed crisis.Pregnant women with SCD have a high risk of morbidity and mortality. Developing acute sickle cell crisis worsened perinatal outcomes.

scholarly journals Prevention of Preeclampsia

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Sammya Bezerra Maia e Holanda Moura ◽  
Laudelino Marques Lopes ◽  
Padma Murthi ◽  
Fabricio da Silva Costa
Keyword(s):  
Secondary Prevention ◽  
Antenatal Care ◽  
Pregnant Women ◽  
Nutritional Supplementation ◽  
Morbidity And Mortality ◽  
Perinatal Morbidity ◽  
Primary And Secondary Prevention ◽  
Care Change

Preeclampsia (PE) affects around 2–5% of pregnant women. It is a major cause of maternal and perinatal morbidity and mortality. In an attempt to prevent preeclampsia, many strategies based on antenatal care, change in lifestyle, nutritional supplementation, and drugs have been studied. The aim of this paper is to review recent evidence about primary and secondary prevention of preeclampsia.

scholarly journals Oxytocin in Induction of Labor in Pregnancy with Group B Streptococcal Portage

2020 ◽  
Vol 25 (3) ◽  
pp. 42-47
Author(s):  
Mihaela Corina Radu ◽  
Anca Irina Dumitrescu ◽  
Adrian Calin Boeru ◽  
Loredana Sabina Cornelia Manolescu ◽  
Oana Roxana Dumitrescu ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Streptococcus Agalactiae ◽  
Group B Streptococcus ◽  
Perinatal Transmission ◽  
Induction Of Labor ◽  
Morbidity And Mortality ◽  
Perinatal Morbidity ◽  
Induced Labor ◽  
Group B ◽  
In Pregnancy

AbstractIn the last two decades, group B streptococcus (GBS) infection has established itself as a major cause of perinatal morbidity and mortality. The purpose of this study is to identify if the electively induced labor with oxytocin in women with positive cultures of Streptococcus agalactiae, namely the group B streptococcus (GBS), helps the mother and fetus and decreases the risk associated with perinatal transmission of GBS compared with the spontaneous labor. Results associated with induction of labor with oxytocin compared with spontaneous labor in pregnant women who have GBS - positive cervical cultures, are also used to determine whether induction of labor decreases the risk of complications from GBS infection.

Oligohydramnios and its perinatal outcome

2020 ◽  
Vol 9 (12) ◽  
pp. 4965
Author(s):  
Rita Saxena ◽  
Brinda Patel ◽  
Anjana Verma
Keyword(s):  
Risk Factors ◽  
Birth Weight ◽  
Low Birth Weight ◽  
Apgar Score ◽  
Perinatal Outcome ◽  
Mode Of Delivery ◽  
Morbidity And Mortality ◽  
Medical Illness ◽  
Perinatal Morbidity ◽  
Nicu Admission

Background: Oligohydramnios is one of the major causes of perinatal morbidity and mortality. The sonographic diagnosis of oligohydramnios is usually based on an AFI≤5 cm or on a single deepest pocket of amniotic fluid≤2 cm3. Our study was aimed to study the perinatal outcome in oligohydramnios. Aim and objective were to study obstetric risk factors associated with oligohydramnios and maternal outcome in the form of mode of delivery, and to assess neonatal complications in terms of APGAR score at birth, NICU admission rates, meconium stained liquor and still birth rates.Methods: It was an Observational, Prospective, clinical study of 100 pregnant patients diagnosed with oligohydramnios by ultrasound, carried out in Geetanjali medical college and hospital, Udaipur for period of from January 2020-August 2020. The study was conducted after ethical clearance and with informed consent. Detailed history on demographic profile, medical illness, obstetric history and antenatal complication if any in the present pregnancy; general examination, obstetric examination and bimanual examination were performed meticulously.Results: In our study 53% cases of oligohydramnios were associated with some of the risk factors like PIH (29%), IUGR (22%), fetal anomaly (1%), systemic maternal disease (1%) and 47% of the cases were Idiopathic. LSCS was done in 85.71% cases with AFI<5 cm. Low birth weight was found in 51.43% cases with AFI<5 cm. NICU admission was required for 28.57% cases with AFI<5 cm.Conclusions: AFI is an important and convenient screening test for prediction of perinatal outcome. In presence of oligohydramnios, the risk of fetal distress, operative delivery, low Apgar score, low birth weight, perinatal morbidity and mortality are more. Hence early detection of oligohydramnios, associated antenatal risk factors and timely management can improve the maternal and fetal outcome.

A STUDY OF PLATELET COUNT AND BLEEDING TIME IN THIRD TRIMESTER OF PREGNANCY WITH REFERENCE TO PRE-ECLAMPSIA.

2021 ◽  
pp. 50-52
Author(s):  
Ranjana Dhar
Keyword(s):  
Platelet Count ◽  
Pregnant Woman ◽  
Pregnant Women ◽  
Bleeding Time ◽  
Morbidity And Mortality ◽  
Age Group ◽  
Time Increase ◽  
Perinatal Morbidity ◽  
Third Trimester ◽  
Pregnancy Result

BACKGROUND: - Pre-eclampsia is a serious complication of pregnancy and contributes signicantly maternal as well as perinatal morbidity and mortality. So an attempt was made to study the platelet count and bleeding time in cases of preeclampsia. AIM:-(1) To nd out the platelet count and bleeding time in pre-eclamptic woman. rd (2) To compare the values of platelet count and bleeding time in pre-eclamptics and normal pregnant woman in 3 trimester of pregnancy. METHODOLOGY:- 120 pregnant women in age group 18-42 years were included in the study of which 40 women were mild pre-eclamptic, 40 severe pre-eclamptic and 40 normal pregnant women in third trimester of pregnancy. RESULT:- Signicant decrease in platelet count and signicant increase in bleeding time was found between pre-eclamptic in comparison with the normal pregnant women. DISCUSSION:- Platelet count was found to decrease & Bleeding Time increase in pre-eclampsia CONCLUSION:- From this study,it was concluded that platelet count decrease and bleeding time incease with increase in severity of preeclampsia

Sign in / Sign up

Export Citation Format

Share Document